Details of the Drug Reposition

General Information of This Drug (ID: DMULZ4W)

Drug Name
CHR-2797   DMULZ4W
Synonyms Tosedostat; Tosedostat, CHR2797, CHR-2797
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myelodysplastic syndrome DISYHNUI 2A37 Phase 2 [1]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 2 [2]
------------------------------------------------------------------------------------
1 Terminated Indication(s)
Indication Name Indication ID ICD-11 Status REF
Inflammation DISJUQ5T 1A00-CA43.1 Terminated [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022187)
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014340)